GlassScriptPhysician profile
Devin Gail Olsen
NPI 1962895367
$21,502.71
in general payments reported to CMS, 2019-2025
7 companies · $2,305 in 2025
The $2,305 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.10 · 2022: $8,827 · 2023: $10K · 2024: $21.29 · 2025: $2,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,667 · Travel and Lodging: $4,116 · Food and Beverage: $1,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,666.67 |
| Travel and Lodging | $4,116.27 |
| Food and Beverage | $1,859.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $13,356.60 | 2022-2023 | |
| Microport Orthopedics INC | $3,360.88 | 2019-2025 | Mpo Medial Pivot Knee |
| Stryker Corporation | $3,234.61 | 2022-2025 | Mako, Insignia |
| Zimmer Biomet Holdings, INC. | $1,152.96 | 2025 | Rosa |
| Depuy Synthes Sales INC. | $315.89 | 2022-2025 | Attune, Lcp, Na |
| Innovation Technologies INC | $64.26 | 2023 | Irrisept |
| Sanofi-Aventis U.S. LLC | $17.51 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Olsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.